Saige-Dx
by DeepHealth, Inc. 3 variants
510(k) K241747
Saige-Dx is a medical device (FDA Class II; FDA product code QDQ) made by DeepHealth, Inc., cleared under FDA 510(k) K241747 on 18 Nov 2024, active as of 11 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK241747 | Date18 Nov 2024 | StatusActive |
Official records
- FDA 510(k) database K241747
From the FDA record
- Received by the FDA
- 18 Jun 2024
- FDA decision
- 18 Nov 2024 (Substantially Equivalent)
- FDA review time
- 153 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QDQ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Genius AI Detection by Hologic, Inc.
- ProFound AI Software V3.0 by Icad, Inc.
- SMART-T Thyroid by See-Mode Technologies Pte, Ltd.
- Transpara by Screenpoint Medical B.V.
- CadAI-B Dx by BeamWorks Inc.
- MammoScreen (3) by Therapixel
- QP-Prostate CAD by QUIBIM S.L.
- PowerLook Tomo Detection V2 Software by Icad, Inc.
- MammoScreen 2.0 by Therapixel
- Genius AI Detection 2.0 with CC-MLO Correlation by Hologic, Inc.